IFRS vs US GAAP: Differences That Matter to Analysts

Two nearly identical manufacturing companies, one headquartered in Frankfurt reporting under IFRS and one in Chicago reporting under US GAAP, can post different profits and different balance sheet totals for the exact same underlying business performance — not because one is hiding anything, but because the two accounting rulebooks make different calls on when to recognize a cost, how to value inventory, and what counts as an asset. An analyst comparing the two without adjusting for these gaps is not comparing companies; they're comparing accounting conventions.

Think of two referees with the same rulebook chapter titles but different specific calls — both care about offside, but one calls it tighter than the other. The game (the underlying business) is the same; the recorded score can still differ because of how strictly each referee applies a similar-sounding rule. IFRS (International Financial Reporting Standards, used across most of the world outside the US) and US GAAP (Generally Accepted Accounting Principles) agree on the big picture but diverge in specific, analytically important ways.

The differences that show up in real numbers

Inventory costing — LIFO. US GAAP permits LIFO (last-in, first-out), where the most recently purchased (usually most expensive, in an inflationary environment) inventory is what gets expensed first, lowering reported profit and reported taxes when prices are rising. IFRS bans LIFO outright, requiring FIFO or weighted-average cost. A US company using LIFO during an inflationary stretch reports lower earnings than an otherwise-identical IFRS company using FIFO — not because it performed worse, but because it expensed more expensive inventory first.

R&D capitalization. US GAAP expenses essentially all research and development immediately, hitting the income statement the moment the cost is incurred. IFRS splits this: pure research is expensed, but development costs — once a project has passed a specific technical and commercial feasibility test — get capitalized as an intangible asset and amortized over its useful life instead. A pharmaceutical or software company reporting under IFRS can show meaningfully higher near-term earnings and a fatter balance sheet than an identical GAAP peer, purely from this timing difference on the same underlying spend.

Asset write-down reversals. Both frameworks require writing an asset down if its value has genuinely fallen (impairment). But if conditions improve later, IFRS permits reversing some of that write-down back up through the income statement (except for goodwill, which is never reversed under either framework). US GAAP forbids reversals entirely — once written down, an asset stays down until disposed of, no matter how much its value recovers. This makes GAAP earnings more conservative and less volatile in the recovery direction, and IFRS earnings more responsive to good news after a bad patch.

Worked example: LIFO's earnings effect

A company holds inventory bought in two batches: 1,000 units at $10 each early in the year, then 1,000 units at $14 each later, as input costs rose. It sells 1,000 units.

• FIFO / weighted-average (IFRS-permitted): cost of goods sold uses the earlier, cheaper batch: $1{,}000 \times$ $10 = $10,000.
• LIFO (GAAP-permitted, IFRS-banned): cost of goods sold uses the later, pricier batch: $1{,}000 \times$ $14 = $14,000.

Same units, same physical inventory, same sale — but LIFO reports $4,000 more cost of goods sold, and therefore $4,000 less pre-tax income, than FIFO. Multiply this across a full inventory turnover cycle at a large industrial company and the earnings gap between two accounting methods, applied to identical operations, can run into tens of millions of dollars.

What this means in practice

Equity analysts comparing companies across accounting regimes routinely restate one to the other before comparing multiples — comparing a US LIFO industrial's P/E directly to a European IFRS peer's P/E without adjustment is a common and material error. Credit analysts adjust for R&D capitalization when comparing leverage ratios, since an IFRS company's larger intangible asset base (from capitalized development costs) can flatter debt-to-assets ratios relative to a GAAP peer expensing the same spend immediately. The gap has narrowed since the early 2000s convergence project between the FASB and IASB — revenue recognition and leases are now largely aligned — but inventory costing, development cost capitalization, and impairment reversal remain live, analytically significant differences that have not converged.

Key terms

• IFRS — International Financial Reporting Standards, used in most jurisdictions outside the US.
• US GAAP — Generally Accepted Accounting Principles, the US reporting standard.
• LIFO — last-in, first-out inventory costing, permitted under GAAP, banned under IFRS.
• Development cost capitalization — IFRS's practice of recording certain R&D spend as an asset rather than an immediate expense.
• Impairment reversal — restoring value to a previously written-down asset; allowed under IFRS (except goodwill), forbidden under GAAP.